Bolignano D et al. measured NGAL in patients affected by non-advanced and non-terminal CKD and found that both serum and urinary levels of NGAL were increased in CKD patients and were inversely correlated with eGFR (Bolignano et al., 2009). Here, LCN2 is linked to chronic kidney disease.